Rahul Jandial, M.D., Ph.D.: Pediatric Neurosurgery Humanitarian Missions

March 13, 2018 | Denise Heady

Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.

Continue Reading

Researchers Discover Breakthrough Treatment For Advanced Squamous Cell Carcinoma

June 7, 2018 | Maxine Nunes

A couple of years ago, Timothy Satterfield, a retired chef, noticed a tiny mole on his forehead. He was referred to City of Hope, where a breakthrough immunotherapy trial is proving to be a game changer.

First FDA-approved CAR T Therapy for Some Types of ALL to Be Offered at City of Hope

April 13, 2018 | Letisia Marquez

City of Hope recently announced that it is a certified treatment center to administer tisagenlecleucel CAR T cell therapy – the first CAR T cell therapy approved by the U.S. Food and Drug Administration – to patients.

Facing Down Uncertainty: Meet Benjamin Djulbegovic, M.D., Ph.D.

March 1, 2018 | Wayne Lewis

The unknown can be scary. But according to City of Hope hematologist Benjamin Djulbegovic, M.D., Ph.D., it’s important to face uncertainty — at least enough to understand it.

Advanced Lung Cancer Patient: ‘I’m Not About to Go Quietly into the Night’

November 30, 2017 | Julia F.

Julie F., 59, of Wisconsin, survived advanced small cell lung cancer after 29 rounds of chemotherapy, five weeks of radiation and experimental immunotherapy. This is her story.

City of Hope’s Alpha Clinic Plots ‘the Future of Nursing’

November 3, 2017 | Wayne Lewis

According to a new paper in Stem Cells Translational Medicine, the authors identify the role of a nurse qualified in both patient care and research protocols, the so-called “hybrid nurse” — a homegrown City of Hope innovation — as an important component of their success in the development of the Alpha Clinic.

Inside the Lab: Preventing breast cancer from invading the brain

July 24, 2017 | Denise Heady

A study led by City of Hope neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., offers novel insights on how cancer cells in HER2-positive breast cancer develop the ability to break through the blood-brain barrier and, ultimately, how they can be stopped.

CAR T cells: ‘Soldiers of the Immune System’

July 10, 2017 | Stephanie Smith

T cells were genetically modified in a lab by City of Hope researchers and trained to target specific receptors on patients’ brain tumors - part of an emerging approach to cancer care called immunotherapy.